-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Turnstone Biologics Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2022 to Q2 2025.
- Turnstone Biologics Corp. Operating Income (Loss) for the quarter ending June 30, 2025 was -$5.56M, a 74.8% increase year-over-year.
- Turnstone Biologics Corp. Operating Income (Loss) for the twelve months ending June 30, 2025 was -$44.5M, a 44.1% increase year-over-year.
- Turnstone Biologics Corp. annual Operating Income (Loss) for 2024 was -$72.5M, a 22.8% decline from 2023.
- Turnstone Biologics Corp. annual Operating Income (Loss) for 2023 was -$59M, a 86.7% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)